Lipidor Investor Relations Material

Latest events

Q1 2024

22 May, 2024

Q4 2023

28 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Lipidor

Access all reports
Lipidor AB is a Swedish company based in Stockholm that specializes in developing topical treatments utilizing unique lipid-based formulations. Their primary focus is on creating formulations for psoriasis treatments. The company leverages its proprietary AKVANO technology, which enables the formation of a lipid layer on the skin surface, facilitating effective drug delivery and skin care treatments. Lipidor collaborates with various global pharmaceutical companies, providing formulation concepts and technologies aimed at improving patient quality of life. They manage the entire development process from preclinical stages to clinical trials, often partnering with external companies for manufacturing and clinical studies. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.